Ultra Performance Liquid Chromatography (UPLC) System Coupled with a Mass Spectrometry (MS) Detector

NON-COMPETITIVE
COMBINED SYNOPSIS / SOLICITATION

Title: Ultra Performance Liquid Chromatography (UPLC) System Coupled with a Mass Spectrometry (MS) Detector

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is NIHDA201800522 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5-Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Station Support Contracts and Simplified Acquisitions Branch (SS/SA) on behalf of the National Center for Advancing Translational Sciences intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Waters Corporation, 34 Maple Street, Milford, MA 01757 or an authorized seller of this manufacturer for an Ultra Performance Liquid Chromatography (UPLC) system coupled with a Mass Spectrometry (MS) detector.

This acquisition is conducted as non-competitive for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5-Simplified Procedures for Certain Commercial Items by soliciting from a single source pursuant to FAR Subpart 13.106-1(b).
Pursuant to FAR Subpart 13.501 (a) (1) (iii) the justification (excluding brand name) will be made available within 14 days after contract award or in the case of unusual and compelling urgency within 30 days after contract award.

Pursuant to FAR Subpart 13.501 (a) (1) (iv) the rationale for the brand name justification is that the Automated Chemistry Group within the Division of Pre-Clinical Innovation (DPI) at NCATS has begun the development and implementation of a high-throughput experimentation (HTE) platform. The unique qualifications provided by the Waters ACQUITY I-Class UPLC-MS system enables these platforms to be highly successful. The Waters ACQUITY I-Class UPLC-MS has the following necessary unique qualifications:
• The binary pump, which is designed for ultra-high-performance liquid chromatography, has the capability to start the gradient at injection, before the injection, or after injection.
• The pump has integrated, automated intake valves for robust reliable performance and priming.
• The pump flow precision is.